The prospective isolation of defined contractile human pluripotent stem cell (hPSC)–derived cardiomyocytes is advantageous for regenerative medicine and drug screening applications. Currently, enrichment of cardiomyocyte populations from such cultures can be achieved by combinations of cell surface markers or the labor-intensive genetic modification of cardiac developmental genes, such as NKX2.5 or MYH6, with fluorescent reporters. To create a facile, portable method for the isolation of contractile cardiomyocytes from cardiomyogenic hPSC cultures, we employed a highly conserved cardiac enhancer sequence in the SLC8A1 (NCX1) gene to generate a lentivirally deliverable, antibiotic-selectable NCX1cp-EGFP reporter. We show that human embryonic stem cells (and induced pluripotent stem cells) transduced with the NCX1cp-EGFP reporter cassette exhibit enhanced green fluorescent protein (EGFP) expression in cardiac progenitors from 5 days into the directed cardiac hPSC differentiation protocol, with all reporter-positive cells transitioning to spontaneously contracting foci 3 days later. In subsequent stages of cardiomyocyte maturation, NCX1cp-EGFP expression was exclusively limited to contractile cells expressing high levels of cardiac troponin T (CTNT), MLC2a/v, and α-actinin proteins, and was not present in CD90/THY1+ cardiac stromal cells or CD31/PECAM+ endothelial cells. Flow-assisted cytometrically sorted EGFP+ fractions of differentiated cultures were highly enriched in both early (NKX2.5 and TBX5) and late (CTNT/TNNI2, MYH6, MYH7, NPPA, and MYL2) cardiomyocyte markers, with a significant proportion of cells displaying a ventricular-like action potential pattern in patch-clamp recordings. We conclude that the use of the cardiac-specific promoter of the human SLC8A1(NCX1) gene is an effective strategy to isolate contractile cardiac cells and their progenitors from hPSC-derived cardiomyogenic cultures.
Get full access to this article
View all access options for this article.
References
1.
ZhangJ, KlosM, WilsonGF, HermanAM, LianX, RavalKK, BarronMR, HouL, SoerensAG, et al. (2012). Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res, 111:1125–1136.
2.
KattmanSJ, WittyAD, GagliardiM, DuboisNC, NiapourM, HottaA, EllisJ and KellerG. (2010). Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell, 8:228–240.
3.
LianX, ZhangJ, ZhuK, KampTJ and PalecekSP. (2013). Insulin inhibits cardiac mesoderm, not mesendoderm, formation during cardiac differentiation of human pluripotent stem cells and modulation of canonical Wnt signaling can rescue this inhibition. Stem Cells, 31:447–457.
4.
HudsonJ, TitmarshD, HidalgoA, WolvetangE and Cooper-WhiteJ. (2012). Primitive cardiac cells from human embryonic stem cells. Stem Cells Dev, 21:1513–1523.
5.
BurridgePW, ThompsonS, MillrodMA, WeinbergS, YuanX, PetersA, MahairakiV, KoliatsosVE, TungL and ZambidisET. (2011). A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. Plos One, 6:e18293
6.
ZhangJ, KlosM, WilsonGF, HermanAM, LianX, RavalKK, BarronMR, HouL, SoerensAG, et al. (2012). Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Cir Res, 111:1125–1136.
7.
KimC, WongJ, WenJ, WangS, WangC, SpieringS, KanNG, ForcalesS, PuriPL, et al. (2013). Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature, 494:105–110.
MercolaM, ColasA and WillemsE. (2013). Induced Pluripotent Stem Cells in Cardiovascular Drug Discovery. Cir Res, 112:534–548.
12.
HoekstraM, MummeryC, WildeAM, BezzinaC and VerkerkA. (2012). Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias. Front Physiol, 3:1–14.
13.
YangL, SoonpaaMH, AdlerED, RoepkeTK, KattmanSJ, KennedyM, HenckaertsE, BonhamK, AbbottGW, et al. (2008). Human cardiovascular progenitor cells develop from a KDR1 embryonic-stem-cell-derived population. Nature, 453:524–528.
14.
LaflammeMA, ChenKY, NaumovaAV, MuskheliV, FugateJA, DuprasSK, ReineckeH, XuC, HassanipourM, et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol, 25:1015–1024.
15.
GuoL, AbramsRMC, BabiarzJE, CohenJD, KameokaS, SandersMJ, ChiaoE and KolajaKL. (2011). Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell–derived cardiomyocytes. Toxicol Sci, 123:281–289.
16.
BraamSR, TertoolenL, van de StolpeA, MeyerT, PassierR and MummeryCL. (2010). Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res, 4:107–116.
17.
LiangP, LanF, LeeAS, GongT, Sanchez-FreireV, WangY, DieckeS, SallamK, KnowlesJW, et al. (2013). Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation, 127:1677–1691.
18.
YokooN, BabaS, KaichiS, NiwaA, MimaT, DoiH, YamanakaS, NakahataT and HeikeT. (2009). The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Biochem Biophys Res Commun, 387:482–488.
19.
Ghafar-ZadehE, WaldeisenJR and LeeLP. (2011). Engineered approaches to the stem cell microenvironment for cardiac tissue regeneration. Lab Chip, 11:3031–3048.
20.
JurgaM, ForrazN and McGuckinCP. (2010). Artificial human tissues from cord and cord blood stem cells for multi-organ regenerative medicine: viable alternatives to animal in vitro toxicology. Altern Lab Anim, 38:183–192.
21.
KehatI, KhimovichL, CaspiO, GepsteinA, ShoftiR, ArbelG, HuberI, SatinJ, Itskovitz-EldorJ and GepsteinL. (2004). Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol, 22:1282–1289.
22.
HuangW, DaiB, WenZ, MillardRW, YuXY, LutherK, XuM, ZhaoTC, YangHT, et al. (2013). Molecular strategy to reduce in vivo collagen barrier promotes entry of NCX1 positive inducible pluripotent stem cells (iPSC(NCX1+)) into ischemic (or injured) myocardium. PLoS One, 8:e70023
23.
ShibaY, FernandesS, ZhuWZ, FiliceD, MuskheliV, KimJ, PalpantNJ, GantzJ, MoyesKW, et al. (2012). Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature, 489:322–325.
24.
LianX, HsiaoC, WilsonG, ZhuK, HazeltineLB, AzarinSM, RavalKK, ZhangJ, KampTJ and PalecekSP. (2012). Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A, 109:E1848–E1857.
25.
MinamiI, YamadaK, OtsujiTG, YamamotoT, ShenY, OtsukaS, KadotaS, MoroneN, BarveM, et al. (2012). Small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell Rep, 2:1448–1460.
26.
MummeryCL, OostwaardDW, DoevendansP, SpijkerR, van den BrinkS, HassinkR, van der HeydenM, OpthofT, PeraM, et al. (2003). Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation, 107:2733–2740.
27.
MummeryCL, ZhangJ, NgES, ElliottDA, ElefantyAG and KampTJ. (2012). Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res, 111:344–358.
FujiuK and NagaiR. (2014). Fibroblast-mediated pathways in cardiac hypertrophy. J Mol Cell Cardiol, 70:64–73.
30.
SanoM, FukudaK, KodamaH, PanJ, SaitoM, MatsuzakiJ, TakahashiT, MakinoS, KatoT and OgawaS. (2000). Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem, 275:29717–29723.
31.
DuboisNC, CraftAM, SharmaP, ElliottDA, StanleyEG, ElefantyAG, GramoliniA and KellerG. (2011). SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol, 29:1011–1018.
32.
SpaterD, AbramczukMK, BuacK, ZangiL, StachelMW, ClarkeJ, SaharaM, LudwigA and ChienKR. (2013). A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells. Nat Cell Biol, 15:1098–1106.
33.
RitnerC, WongSSY, KingFW, MihardjaSS, LiszewskiW, ErleDJ, LeeRJ and BernsteinHS. (2011). An engineered cardiac reporter cell line identifies human embryonic stem cell-derived myocardial precursors. PLOS One, 6:e16004
34.
FuJ-D, JiangP, RushingS, LiuJ, ChiamvimonvatN and LiRA. (2010). Na+/Ca2+ exchanger is a determinant of excitation–contraction coupling in human embryonic stem cell–derived ventricular cardiomyocytes. Stem Cells Dev, 19:773–782.
35.
BarthAS, KizanaE, SmithRR, TerrovitisJ, DongP, LeppoMK, ZhangY, MiakeJ, OlsonEN, et al. (2008). Lentiviral vectors bearing the cardiac promoter of the Na+-Ca2+ exchanger report cardiogenic differentiation in stem cells. Mol Ther, 16:957–964.
36.
ElliottDA, BraamSR, KoutsisK, NgES, JennyR, LagerqvistEL, BibenC, HatzistavrouT, HirstCE, et al. (2011). NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods, 8:1037–1040.
37.
LitwinSE, LiJ and BridgeJHB. (1998). Na-Ca exchange and the trigger for sarcoplasmic reticulum Ca release: studies in adult rabbit ventricular myocytes. Biophys J, 75:359–371.
38.
LevesquePC, LeblancO and HumeJ. (2006). Role of reverse-mode Na+- Ca2+ exchange in excitation- contraction coupling in the heart. Abb N Y Acad Sci, 639:386–397.
39.
BriggsJA, SunJ, ShepherdJ, OvchinnikovDA, ChungTL, NaylerSP, KaoLP, MorrowCA, ThakarNY, et al. (2012). Integration-free induced pluripotent stem cells model genetic and neural developmental features of Down syndrome etiology. Stem Cells, 31:467–478.
40.
OvchinnikovDA, TurnerJP, TitmarshDM, ThakarNY, SinDC, Cooper-WhiteJJ and WolvetangEJ. (2012). Generation of a human embryonic stem cell line stably expressing high levels of the fluorescent protein mCherry. World J Stem Cells, 4:71–79.
41.
LianX, ZhangJ, AzarinSM, ZhuK, HazeltineLB, BaoX, HsiaoC, KampTJ and PalecekSP. (2013). Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nat Protoc, 8:162–175.
42.
HeJQ, MaY, LeeY, ThomsonJA and KampTJ. (2003). Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res, 93:32–39.
43.
SatinJ, KehatI, CaspiO, HuberI, ArbelG, ItzhakiI, MagyarJ, SchroderEA, PerlmanI and GepsteinL. (2004). Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J Physiol, 559:479–496.
44.
QianL, HuangY, SpencerCI, FoleyA, VedanthamV, LiuL, ConwaySJ, FuJD and SrivastavaD. (2012). In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature, 485:593–598.
45.
DomianIJ, ChiravuriM, van der MeerP, FeinbergAW, ShiX, ShaoY, WuSM, ParkerKK and ChienKR. (2009). Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science, 326:426–429.
46.
ArdehaliR, AliSR, InlayMA, AbilezOJ, ChenMQ, BlauwkampTA, YazawaM, GongY, NusseR, DrukkerM and WeissmanIL. (2013). Prospective isolation of human embryonic stem cell-derived cardiovascular progenitors that integrate into human fetal heart tissue. Proc Natl Acad Sci U S A, 110:3405–3410.
47.
NicholasSB, YangW, LeeSL, ZhuH, PhilipsonKD and LyttonJ. (1998). Alternative promoters and cardiac muscle cell-specific expression of the Na+/Ca2+ exchanger gene. Am J Physiol, 274:H217–H232.
48.
LinckB, QiuZ, HeZ, TongQ, HilgemannDW and PhilipsonKD. (1998). Functional comparison of the three isoforms of the Na+/Ca2+ exchanger (NCX1, NCX2, NCX3). Am J Physiol, 274:C415–C423.
49.
BoymanL, MikhasenkoH, HillerR and KhananshviliD. (2009). Kinetic and equilibrium properties of regulatory calcium sensors of NCX1 protein. J Biol Chem, 284:6185–6193.
50.
KobanMU, BrughSA, RiordonDR, DellowKA, YangHT, TweedieD and BohelerKR. (2001). A distant upstream region of the rat multipartite Na(+)-Ca(2+) exchanger NCX1 gene promoter is sufficient to confer cardiac-specific expression. Mech Dev, 109:267–279.
51.
BurridgePW, KellerG, GoldJD and WuJC. (2011). Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell, 10:16–28.
52.
CamellitiaP, BorgbTK and KohlaP. (2005). Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res, 65:40–51.
53.
ChristoforouN, MillerRA, HillCM, JieCC, McCallionAS and GearhartJD. (2008). Mouse ES cell-derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes. J Clin Invest, 118:894–903.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
